Bio-Techne Corp (TECH)
62.68
-0.84
(-1.32%)
USD |
NASDAQ |
Apr 25, 16:00
62.68
0.00 (0.00%)
After-Hours: 20:00
Bio-Techne Enterprise Value: 10.30B for April 24, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 10.30B |
| April 23, 2024 | 10.32B |
| April 22, 2024 | 10.18B |
| April 19, 2024 | 10.08B |
| April 18, 2024 | 10.09B |
| April 17, 2024 | 10.17B |
| April 16, 2024 | 10.37B |
| April 15, 2024 | 10.61B |
| April 12, 2024 | 10.80B |
| April 11, 2024 | 11.13B |
| April 10, 2024 | 11.24B |
| April 09, 2024 | 11.51B |
| April 08, 2024 | 11.03B |
| April 05, 2024 | 10.84B |
| April 04, 2024 | 10.85B |
| April 03, 2024 | 10.98B |
| April 02, 2024 | 11.12B |
| April 01, 2024 | 11.22B |
| March 28, 2024 | 11.38B |
| March 27, 2024 | 11.22B |
| March 26, 2024 | 11.06B |
| March 25, 2024 | 11.19B |
| March 22, 2024 | 11.55B |
| March 21, 2024 | 11.68B |
| March 20, 2024 | 11.61B |
| Date | Value |
|---|---|
| March 19, 2024 | 11.43B |
| March 18, 2024 | 11.61B |
| March 15, 2024 | 11.71B |
| March 14, 2024 | 11.51B |
| March 13, 2024 | 11.71B |
| March 12, 2024 | 11.96B |
| March 11, 2024 | 12.12B |
| March 08, 2024 | 12.43B |
| March 07, 2024 | 12.41B |
| March 06, 2024 | 12.05B |
| March 05, 2024 | 11.85B |
| March 04, 2024 | 12.08B |
| March 01, 2024 | 12.00B |
| February 29, 2024 | 11.88B |
| February 28, 2024 | 12.00B |
| February 27, 2024 | 11.82B |
| February 26, 2024 | 11.62B |
| February 23, 2024 | 11.57B |
| February 22, 2024 | 11.59B |
| February 21, 2024 | 11.59B |
| February 20, 2024 | 11.37B |
| February 16, 2024 | 11.57B |
| February 15, 2024 | 11.51B |
| February 14, 2024 | 11.33B |
| February 13, 2024 | 10.92B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
6.320B
Minimum
Mar 16 2020
21.26B
Maximum
Sep 24 2021
12.46B
Average
12.08B
Median
Enterprise Value Benchmarks
| Agilent Technologies Inc | 41.10B |
| Bio-Rad Laboratories Inc | 7.527B |
| Revvity Inc | 14.98B |
| Twist Bioscience Corp | 1.467B |
| AIM ImmunoTech Inc | 9.076M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 27.46M |
| Revenue (Quarterly) | 272.60M |
| Total Expenses (Quarterly) | 234.59M |
| EPS Diluted (Quarterly) | 0.17 |
| Gross Profit Margin (Quarterly) | 64.78% |
| Profit Margin (Quarterly) | 10.08% |
| Earnings Yield | 2.20% |
| Operating Earnings Yield | 2.58% |
| Normalized Earnings Yield | 2.199 |